<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR50">
 <label>50.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Guedj</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Perelson</surname>
    <given-names>AS</given-names>
   </name>
  </person-group>
  <article-title>Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: implications for treatment duration</article-title>
  <source>Hepatology</source>
  <year>2011</year>
  <volume>53</volume>
  <fpage>1801</fpage>
  <lpage>1808</lpage>
  <pub-id pub-id-type="doi">10.1002/hep.24272</pub-id>
  <?supplied-pmid 21384401?>
  <pub-id pub-id-type="pmid">21384401</pub-id>
 </element-citation>
</ref>
